Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

NCT00927472 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediculosis

Interventions

DRUG: Malathion gel 0.5%
DRUG: Permethrin 1% rinse

Sponsor

Sun Pharmaceutical Industries, Inc.